Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion

Vox Sanguinis

Volumn 94, Issue 3, 2008, Pages 172-183

  Munoz M ^a   Breymann, C ^b   Garcia Erce J A ^c   Gomez Ramirez S ^d   Comin, J ^e   Bisbe, E ^e  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e Esperanza and Mar Hospital   (Spain)

Author keywords

Anaemia; Blood transfusion; Inflammation; Intravenous iron; Iron deficiency

Indexed keywords

CARBOHYDRATE DERIVATIVE; ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROUS GLUCONATE; HEPCIDIN; IRON; IRON DEXTRAN; NANOPARTICLE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; SODIUM FERROUS CITRATE; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANAPHYLAXIS; BLOOD TRANSFUSION; CAPILLARY LEAK SYNDROME; CHRONIC INFLAMMATION; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG SAFETY; FOOT EDEMA; HAND EDEMA; HUMAN; HYPOTENSION; INJECTION SITE PAIN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; NAUSEA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; SURGICAL PATIENT; TACHYCARDIA;

ANAPHYLAXIS; ANEMIA, IRON-DEFICIENCY; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; CRITICAL CARE; FEMALE; HEART FAILURE; HUMANS; INFECTION; INFLAMMATORY BOWEL DISEASES; INJECTIONS, INTRAVENOUS; INTRAOPERATIVE PERIOD; IRON; IRON OVERLOAD; KIDNEY FAILURE, CHRONIC; NEOPLASMS; OXIDATIVE STRESS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; SAFETY;

EID: 40749088084     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2007.01014.x     Document Type: Review

References (73)

1. Muñoz M, Campos A, García-Erce JA, Ramírez G : Fisiopatología del metabolismo del hierro: implicaciones diagnósticas y terapéuticas. Nefrología 2005 25 : 9 19
2. Hersko C : Prevalence and causes of iron deficiency anaemia in Beaumont C, Beris P, Beuzard Y, Brugnara C (eds) : Disorders of Iron Homeostasis, Erythrocytes, Erythropoiesis. Paris, European School of Haematology, 2006 : 409 419
3. Goognough LT : The relevance of iron in erythropoietin-stimulated erythropoiesis. Semin Hematol 2006 43 (Suppl. 6 S3 S8
4. Cook JD, Flowers CH, Skikne BS : The quantitative assessment of body iron. Blood 2003 101 : 3359 3363
5. Weiss G, Goodnough LT : Anemia of chronic disease. N Engl J Med 2005 352 : 1011 1023
6. Scottish Intercollegiate Guidelines Network : Perioperative Blood Transfusion for Elective Surgery: A National Clinical Guideline. Available at http://www.sign.ac.uk/guidelines/fulltext/54/index.html, 2001 (update in 2004)
7. Fishbane S, Kowalski EA : The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. Semin Dial 2000 13 : 381 384
8. Silverstein SB, Rodgers GM : Parenteral iron therapy options. Am J Hematol 2004 76 : 74 78
9. Aronoff GR : Safety of intravenous iron in clinical practice: implications for anemia management protocols. J Am Soc Nephrol 2004 15 : S99 S106
10. Van Wyck DB. Labile iron: manifestations and clinical implications. J Am Soc Nephrol 2004 15 (Suppl. 2 S107 S111
11. Danielson BG : Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol 2004 15 : S93 S98
12. Grau PW : Intravenous iron therapy in Beaumont C, Beris P, Beuzard Y, Brugnara C, (eds Disorders of Iron Homeostasis, Erythrocytes, Erythropoiesis. Paris, European School of Haematology, 2006 : 420 434
13. Chertow GM, Mason PD, Vaaga-Nilsen O, Ahlmén J : Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006 21 : 378 382
14. Weiss G : Iron and immunity: a double-edged sword. Eur J Clin Invest 2003 32 (Suppl. 1 70 78
15. Vychytil A, Haag-Weber M : Iron status and iron supplementation in peritoneal dialysis patients. Kidney Int 1999 55 (Suppl S71 S78
16. Hoen B, Paul-Dauphin A, Hestin D, Kessler M : EPIBACDIAL: a mulitcenter prospective study of risk factors for bacteremia in chronic hemodyalysis patients. J Am Soc Nephrol 1998 9 : 869 876
17. Breymann C : The use of iron sucrose complex for anemia in pregnancy and the postpartum period. Semin Haematol 2006 43 (Suppl. 6 S28 S31
18. Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxemaire MC : Iron therapy in iron deficency anemia in pregnancy: intravemous route versus oral route. Am J Obstet Gynecol 2002 186 : 518 522
19. Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A : Intravenous versus oral iron for treatment of anemia in pregnancy. A randomized trial. Obstet Gynecol 2005 106 : 1335 1340
20. Al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, Abbas M : Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996 69 : 121 124
21. Breymann C, Zimmermann R, Huch R, Huch A : Use of recombinant erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia. Eur J Clin Invest 1996 26 : 123 130
22. Broche DE, Gay C, Armand-Branger S, Grangeasse L, Terzibachian JJ : Anémies sévères du post-parum inmediat. Practique clinique et intérêt du fer par voie intraveineuse. Gynecol Obstet Fertil 2004 32 : 613 619
23. Bhandal N, Russell R : Intravenous versus oral iron therapy for postpartum anaemia. Br J Obstet Gynaecol 2006 113 : 1248 1252
24. Breymann C, Richter C, Hüttner C, Huch R, Huch A : Effectivenes of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest 2000 30 : 154 156
25. Gasche C, Lomer MCE, Cavill I, Weiss G : Iron, anaemia, and inflammatory bowel diseases. Gut 2004 53 : 1190 1197
26. Gasche C, Kulnigg S : Intravenous iron in inflammatory bowel disease. Semin Hematol 2006 43 (Suppl. 6 S18 S22
27. Bodemar G, Kechagias S, Almer S, Danielson BG : Treatment of anemia in inflammatory bowel disease with iron sucrose. Scand J Gastroenterol 2004 39 : 454 458
28. Schroder O, Mickisck O, Seidler U, de Weerth A, Dignass AU, Herfath H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J : Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-A randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005 100 : 2503 2509
29. Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T : Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005 40 : 1058 1065
30. Ezekowitz JA, Mcalister FA, Amstromg PW : Anemia is common in heart failure and is associated with poor outcomes. Insights from a cohort of 12065 patients with new-onset heart failure. Circulation 2003 107 : 223 225
31. Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabro A, Campagna MS, Nuti R : Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 2006 152 : 1096. e9 e15
32. Bolger AP, Barlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Capman CM : Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006 48 : 1225 1227
33. Beck-da-Silva L, Rohde LE, Pereira-Barretti AC, de Albuquerque D, Bocchi E, Vilas-Boas E, Moura LZ, Montera MW, Rassi S, Clausell N : Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. J Cardiac Fail 2007 13 : 14 17
34. Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Laina A : The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Clin Nephrol 2001 55 : 212 219
35. Sargent JA, Acchiardo SR : Iron requirements in hemodialysis. Blood Purif 2004 22 : 112 123
36. Mircescu G, Garneata L, Capusa C, Ursea N : Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Nephrol Dial Transplant 2006 21 : 120 124
37. Henry DH, Dahl NV Ferrlecit Cancer Study Group : Iron and B12 parameters in anemic cancer patients on chemotherapy presenting for epoetin alpha (EPO) therapy [Abstract]. J Clin Oncol 2004 22 (Suppl. 8091
38. Auerbach M, Ballrad H, Trout JR, Mcilwain M, Ackerman A, Bahrain H, Balan S, Barker L, Rana J : Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, amdimized trial. J Clin Oncol 2004 22 : 1301 1307
39. FDA ALERT : Erythropoiesis Stimulating Agents (ESA) (11/16/2006, Updated 2/16/2007 and 3/09/2007). Available at http://www.fda.gov/cder/drug/advisory/ RHE2007.htm
40. Shander A, Knight K, Thurer R, Adamson J, Spence R : Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2006 116 : 58S 69S
41. Van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJM, Van de Wiel A : Iron metabolism and erythropoiesis after surgery. Br J Surg 1998 85 : 41 45
42. Muñoz M, Romero A, Morales M, Campos A, García-Erce JA, Ramírez G : Iron metabolism, inflammation, and anemia in critically ill patients. A cross-sectional study. Nutr Hosp 2005 20 : 110 116
43. Cuenca J, García-Erce JA, Muñoz M, Izuel M, Martínez AA, Herrera A : Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004 44 : 1447 1452
44. Cuenca J, García-Erce JA, Martínez AA, Solano VM, Molina J, Muñoz M : Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair. Preliminary data. Arch Orthop Trauma Surg 2005 125 : 342 347
45. García-Erce JA, Cuenca J, Muñoz M, Izuel M, Martínez AA, Herrera A, Solano VM, Martínez F : Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005 88 : 235 243
46. Bisbe E, Rodríguez C, Ruiz A, Sáez M, Castillo J, Santiveri X : Uso preoperatorio de hierro endovenoso. Una nueva terapéutica en medicina transfusional. Rev Esp Anestesiol Reanim 2005 52 : 536 540
47. Cuenca J, García-Erce JA, Martínez F, Pérez-Serrano L, Herrera A, Muñoz M : Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006 46 : 1112 1119
48. Weber EWG, Slappendel R, Hémon Y, Mahler S, Dalen T, Rouwet E, van Os J, Vosmaer A, van der Ark P : Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesth 2005 22 : 249 257
49. Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T : Treatment of anaemia after joint replacement. J Bone Joint Surg (Br) 2004 86-B : 31 33
50. Wheatheral M, Maling TJ : Role iron therapy for anaemia after orthopaedic surgery: randomized clinical trial. ANZ J Surg 2004 74 : 1049 1051
51. Mundy GM, Birtwistle SJ, Power RA : The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty. J Bone Joint Surg (Br) 2005 87-B : 213 217
52. Bernière J, Dehullu JP, Gall O, Murat I : Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents. Rev Chir Orthop 1998 84 : 319 322
53. Muñoz M, Naveira E, Seara J, Palmer JH, Cuenca J, García-Erce JA : Role of parenteral iron on tranfusion requirements after total hip replacement. A pilot study. Transfus Med 2006 16 : 137 142
54. Karkouti K, Mccluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM : Intravenous iron and recombinant human erythropoietin for the treatment of postoperative anaemia. Can J Anesth 2006 53 : 11 19
55. García-Erce JA, Cuenca J, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M : Perioperative intravenous iron may transfusion requirements and hasten the recovery from postoperative anaemia after knee replacement surgery. Transfus Med 2006 16 : 335 341
56. Wallis JP, Wells AW, Whitehead S, Brewster N : Recovery from post-operative anaemia. Tranfus Med 2005 15 : 413 418
57. Crosby L, Palarski VA, Cottington E, Cmolik B : Iron supplementation for acute blood loss anemia alter cornary artery bypass surgery: a randomized, placebo-controlled study. Heart Lung 1994 23 : 493 499
58. Madi-Jebara S, Sleilaty GS, Achouh PE, Yazigi AG, Haddad FA, Hayek GM, Anatkly MC, Jebara Val : Postoperative intravenous iron used alone or in combination with low-dose erythropoietin in not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004 18 : 59 63
59. Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM. Intravenous iron following cardiac surgery does not increase the infection rate. Surg Infect (Larchmt) 2006 7 : 361 366
60. Muñoz M, Leal-Noval R, García-Erce JA : Intravenous iron in cardiac surgery. Semin Hematol 2006 43 (Suppl. 6 S39 S42
61. Okuyama M, Ikeda K, Shibata T, Tsukahara Y, Kitada M, Shimano T : Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 2005 35 : 36 40
62. Muñoz M, Campos A, García-Erce JA : Intravenous iron in colorectal cancer surgery. Semin Hematol 2006 43 : S36 S38
63. Larson B, Bremme K, Clyne N, Nordstrom L : Preoperative treatment of anemic women with epoetin β. Acta Obstet Gynecol Scand 2001 80 : 559 562
64. Dousias V, Paraskevaidis E, Dalkalitsis N, Tsanadis G, Navrozoglou I, Lolis D : Recombinant human erythropoietin in mildly anemic women before total hysterectomy. Clin Exp Obstet Gynecol 2003 30 : 235 238
65. Gredilla E, Gimeno M, Canser E, Martínez B, Pérez-Ferrer A, Gilsanz F : Tratamiento de la anemia en el postparto y en el postoperatorio inmediato de cirugía ginecológica, con hierro intravenoso. Rev Esp Anestesiol Reanim 2006 53 : 208 213
66. Bellamy MC, Gedney JA : Unrecognised iron deficiency in critical illness. Lancet 1998 352 : 1903
67. Van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, Van de Wiel A : Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000 28 : 2773 2778
68. Georgopoulos D, Matamos D, Routsi C, Michalopoulos A, Margina N, Dimopoulos G, Zakynthions E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A, Critical Care Clinial Trials Greek Group : Recombinant human erythropoietin therapy in critically ill patients: a dose-response study. Crit Care 2005 9 : R508 R515
69. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T, EPO: Critical Care Trials Group : Efficacy of recombinant human erythropoietin in critically ill patients: a randomized, controlled trial. JAMA 2002 288 : 2827 2835
70. Mercuriali F, Inghilleri M : Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996 13 : 465 478
71. Goodnough LT, Shander A, Spivak JL, Waters JH, Friedman AJ, Carson JL, Keating EM, Maddox T, Spence R : Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005 101 : 1858 1861
72. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC : The prevalence of anemia in persons aged 65 and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004 104 : 2263 2268
73. Leal R, Alberca I, Asuero MS, Boveda JL, Carpio N, Contreras E, Fernandez-Mondejar E, Forteza A, Garcia-Erce JA, Garcia de Lorenzo A, Gomar C, Gomez A, Llau JV, Lopez-Fernandez MF, Moral V, Muñoz M, Paramo JA, Torrabadella P, Quintana M, Sanchez C : Documento 'Sevilla' de Consenso sobre alternativas a la transfusión alogénica. Med Clin (Barc) 2006 127 (Suppl. 1 3 20